This study is comparing Celecoxib with placebo for people with depression or Inflammation. Participants receive Celecoxib or placebo and complete study visits and assessments.
In Belgium
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
This study is looking at whether questionnaires and follow-up can help people with Multimorbidity, Depression - Depression in bipolarity, or Integrated Care. Participants receive integrated care intervention tailored to the needs of older adults leaving at home with mood disorders and multimorbidity in Leuven or usual care and complete study visits and assessments.
This study is looking at whether The study is a multi-center community unblinded interventional study can help people with Promotion of mental health and prevention of depression and anxiety or Mental and Behavioural Disorders. Participants take part in The study is a multi-center community unblinded interventional study and complete follow-up assessments.
This observational study is following people with Lower Urinary Tract Symptoms, Neurodevelopmental Disorders, Incontinence, Urinary, or Adhd to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether psychoeducation can help people with Postpartum parents experiencing challenges related to early parenthood, with a focus on improving parental wellbeing and supporting infant mental health during the first year after birth or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at care and outcomes for people with Old Age or depression, Treatment-Resistant. Some participants may receive Sham adTMS instead of the study treatment, and direct benefit is not guaranteed.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.